Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma

BACKGROUND: Osteosarcoma is one of the most common bone cancers in children. Most patients with metastatic osteosarcoma die of pulmonary disease and limited curative therapeutic options exist for such patients. We have previously shown that PD-1 limits the efficacy of CTL to mediate immune control o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lussier, Danielle M, Johnson, John L, Hingorani, Pooja, Blattman, Joseph N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437699/
https://www.ncbi.nlm.nih.gov/pubmed/25992292
http://dx.doi.org/10.1186/s40425-015-0067-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437699/
https://www.ncbi.nlm.nih.gov/pubmed/25992292
http://dx.doi.org/10.1186/s40425-015-0067-z

Ejemplares similares